Abstract
Na+‐H+‐exchanger‐1 (NHE‐1) controls intracellular pH and glycolytic enzyme activities, and its expression and activity are increased by diabetes. We evaluated the role for NHE‐1 in diabetic cataract formation and retinal oxidative‐nitrosative stress and apoptosis. Control and STZ‐diabetic rats were treated with/without the NHE‐1 inhibitor cariporide (C, Sanofi‐Aventis, 10 mgkg−1d−1) for 1(lens biochemistry) and 3.5 mo. In in vitro studies, bovine retinal pericytes and endothelial cells were cultured in 5 or 30 mM glucose, with or without 10 μM C, for 7 d. C treatment delayed, but did not prevent, diabetic cataractogenesis. This was probably related to inhibition of oxidative‐nitrosative stress in the lens. Diabetes‐induced accumulation of glucose and sorbitol pathway metabolites was not affected. The number of TUNEL positive cells was increased 4.4‐fold in the retina of diabetic rats, and this increase was attenuated, but not completely prevented, by C. Nitrotyrosine fluorescence and TUNEL positivity were increased in pericytes and endothelial cells cultured in 30 mM glucose, and both nitrosative stress and cell death were at least partially prevented by C. In conclusion, NHE‐1 contributes to diabetic cataract formation and retinal oxidative‐nitrosative stress and apoptosis. The findings identify a new therapeutic target for diabetic ocular complications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.